
GC13147
Enasidenib
Also listed as AG-221 (Enasidenib)
AG-221 (Enasidenib) is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively
ChemicalCAS1446502-11-9MW473.37FormulaC19H17F6N7O
- CAS number
- 1446502-11-9
- Molecular weight
- 473.37
- Formula
- C19H17F6N7O
- Solubility
- ≥ 47·3mg/mL in DMSO
- InChIKey
- DYLUUSLLRIQKOE-UHFFFAOYSA-N
- Catalogue number
- GC13147
- Brand
- GLPBIO
Computed properties PubChem CID 89683805 · XLogP 3.5 · TPSA 109 Ų · H-bond donors 3
- XLogP
- 3.5
- TPSA
- 109 Ų
- H-bond donors
- 3
- H-bond acceptors
- 14
- Rotatable bonds
- 6
- Heavy atoms
- 33
SMILES CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O
Computed descriptors from PubChem (CID 89683805), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il